Overview
Find My Formula creates personalized nootropic supplements to boost cognitive performance. It serves adults 18+ and uses a proprietary assessment to identify individual baseline cognitive functions and goals, then designs customized supplement blends. The products work by combining ingredients with cognitive benefits (for example choline sources to support memory and learning) into tailored formulas, delivered direct-to-consumer through a subscription model for ongoing use. What sets Find My Formula apart is its emphasis on highly personalized solutions backed by scientific research and customer testimonials, plus transparent information about ingredients and dosages and guidance to consult healthcare professionals before starting any regimen. The company’s goal is to help people improve mental performance and overall well-being while building a steady subscription-based business in the growing nootropics market.
Work here?Claim your company
Simplify's take
What believers are saying
- The thesis.com rebrand updated formulas and launched live claims pages on November 8, 2026.
- Series A funding reached $8.4 million, with total funding above $13.5 million.
- Recent 2025 studies and active hiring signal continued investment in growth and retention.
What critics are saying
- Racetams, vinpocetine, and noopept draw FDA scrutiny, forcing reformulation or shutdown.
- Open-label consumer studies with $10 store credit do not prove efficacy, and rivals copy personalization.
- If regulators restrict nootropic claims, Thesis loses its core differentiation and subscription engine.
What makes Formula unique
- Thesis, formerly Formula, uses quiz-driven nootropic personalization and iterative formula updates.
- Its website claims data-driven formulations and open-label consumer studies on current blends.
- The brand sells subscription-based Energy, Logic, Creativity, and Motivation stacks, not commodity pills.
Help us improve and share your feedback! Did you find this helpful?